Biohaven shareholders approve 2026 meeting proposals
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Biohaven Ltd. reported the results of its 2026 annual meeting of shareholders. Shareholders elected Michael T. Heffernan, Irina Antonijevic, M.D., Ph.D., and Robert J. Hugin as directors for terms expiring at the 2029 annual meeting, each receiving over 76 million votes in favor and more than 14 million votes against, with additional abstentions and 32,137,064 broker non-votes.
Shareholders also approved the ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, with 123,723,636 votes for, 214,123 against, and 1,410,634 abstentions. In addition, they approved the non-binding advisory vote on compensation for the company’s named executive officers, with 87,521,620 votes for, 4,202,883 against, 1,486,826 abstentions, and 32,137,064 broker non-votes.
8-K Event Classification
Key Figures
Key Terms
Annual Meeting financial
Broker Non-Votes financial
independent auditors financial
advisory vote financial
named executive officers financial
Emerging growth company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which directors were elected at Biohaven Ltd. (BHVN)’s 2026 annual meeting?
What were the results of Biohaven Ltd. (BHVN)’s say-on-pay advisory vote in 2026?
Were there broker non-votes at Biohaven Ltd. (BHVN)’s 2026 annual meeting?
AI-generated analysis. How Rhea-AI works. Not financial advice.